States, where there is a case-fatality rate of 15%-29% in individuals 170 years old and no consistently effective treatment. Susceptibility to WNV disease in inbred strains of mice was mapped to a nonsense mutation in the gene encoding the 1b isoform of 2 -5 -oligoadenylate synthetase (OAS), a member of the OAS/RNase L system of innate viral resistance. Genetic susceptibility to severe WNV disease in humans has not been determined.
WNV is a positive-sense, single-stranded and enveloped RNA virus within the Flaviviridae family. The natural transmission cycle of WNV involves birds and mosquitoes of the genus Culex, with horses and humans being incidental hosts [4] . Laboratory diagnosis is made by serological assessment, and no WNV disease-specific treatment or vaccine is presently available [5] . In humans, most cases of WNV disease are subclinical; however, a small percentage of patients (р1%) develop clinical infections ranging in severity from WNV fever to fatal meningoencephalitis. The incidence of severe neuroinvasive disease and death from WNV infection increases with age [1, 6] . Although environmental factors and comorbidities may contribute to susceptibility to severe WNV disease [7] , studies in mice suggest that host-dependent genetic factors may play an important role [8] [9] [10] .
Inbred strains of laboratory mice develop severe meningoencephalitis and die after inoculation with WNV and other flaviviruses, whereas mice in the wild do not. This susceptibility to severe WNV disease in inbred Figure 1 . Schematic outline of the 2-5A system of innate viral resistance, its induction by interferon (IFN), and how the truncated 1b isoform of oligoadenylate synthetase (OAS; Oas1b-C820T) in mice and OASL in humans may interfere with its antiviral action. IFN-a/IFN-b or IFN-g binds to its cognate receptors, which leads to the formation of IFN-stimulated gene factor (ISGF) 3, a complex of signal transducer and activator of transcription (STAT) 1, STAT2, and p48, or of STAT1 homodimers, respectively. These complexes translocate to the nucleus, resulting in transcriptional up-regulation of members of the OAS family. OAS is activated (OAS*) by double-stranded RNA (dsRNA); RNase L is activated (RNase L*) by 2 -5 -oligoadenylate (2,5 A), which degrades dsRNA. Both Oas1b-C820T and OASL are postulated to interfere with the 2-5A system through blocking OAS activation. Chr, chromosome.
strains has been mapped to a nonsense mutation (C820T) in exon 4 of the gene encoding the 1b isoform of the 2 -5 -oligoadenylate synthetase (OAS) family [9, 10] . This enzyme is part of the 2-5A system of innate immune resistance to viral infection (figure 1). This resistance pathway involves generation of 2 -5 -oligoadenylate with the general structure ppp(A2 p) n A. Oligoadenylate activates an endoribonuclease, RNase L, which degrades viral RNA [11] . Synthesis of 2 -5 -oligoadenylate is catalyzed by members of the 2 -5 -OAS family [12] . Levels of 2 -5 -OAS within cells are increased at the transcriptional level by interferon (IFN) exposure. IFN-a/IFN-b activates and induces nuclear translocation of the transcription factor complex IFN-stimulated gene factor 3, which is composed of signal transducer and activator of transcription (STAT) 1, STAT2, and p48. IFN-g exposure leads to homodimerization and nuclear translocation of STAT1. Viral infection causes production of doublestranded RNA (dsRNA), which activates 2 -5 -OAS. The 2 -5 -OAS family also plays an important role in cellular processes, such as growth control, differentiation, and apoptosis [13] [14] [15] . The nonsense mutation C820T in exon 4 of the mutant Oas1b gene [9, 10] results in expression of a truncated protein that lacks the 25A_SYNTH_2 domain [16] , which is highly conserved within the genes for the 2 -5 -OAS family, as well as the CFK sequence, which is required for tetramerization of Oas1 isoenzymes and their enzymatic activity [17] . Recent studies have demonstrated that WNV is replicated to higher copy number in neurons overexpressing Oas1b-C820T than in neurons overexpressing wild-type Oas1b [18] , which suggests that Oas1b-C820T may function as a dominant-negative mutant.
In humans, the 2 -5 -OAS family is encoded by 4 genes, 3-OAS1, OAS2, and OAS3-that produce proteins with enzymatic activity, and 1-OASL (named for being OAS-like)-that produces proteins that are enzymatically inactive. To determine if susceptibility to severe WNV disease could be mapped to mutations in genes within the 2-5A system of innate viral resistance, we sequenced all exons, as well as 25 bases of flanking intronic regions, of the OAS and RNASEL genes in 33 unrelated individuals hospitalized with severe WNV disease. Sequencing did not reveal any insertions, deletions, or nonsense mutations; however, comparison of the exons and flanking sequences between case patients and control subjects identified a synonymous single nucleotide polymorphism (SNP) in OASL1 exon 2, in which the reference allele occurred at a higher frequency in case patients than in control subjects and contained a splice enhancer sequence. These results suggest that RNA transcripts from this allele may undergo increased splicing, resulting in a dominant-negative OASL1 isozyme that is similar to the truncation mutant form of Oas1b in mice.
SUBJECTS, MATERIALS, AND METHODS

Study populations.
Patients who received diagnoses of WNV disease in Harris County, Texas, during January 2002-December 2003 were contacted by an investigator and were invited to participate in the study. The human-experimentation guidelines of the US Department of Health and Human Services and those of the institutional review boards of the authors' institutions were followed in the conduct of the research, and informed consent to participate in the study was obtained from patients or their guardians. The diagnosis of WNV disease and its classification (fever, meningitis, or encephalitis) were made after review of the medical records by local public health authorities and on the basis of symptoms and signs consistent with WNV disease [19] combined with either a positive result for IgM in cerebrospinal fluid or that paired with a positive result for serum IgM, as identified by the City of Houston Department of Health and Human Services Public Health Laboratory. A venous blood sample (10 mL of whole blood, collected in a green-top tube) was collected from each case patient. Genomic DNA was extracted from blood by use of the Flexi Gene DNA kit (Qiagen).
The control group consisted of 60 healthy adult Utah residents of northern and western European ancestry. Genomic DNA was originally isolated from the blood of these individuals in 1980 by the Centre d'Etude du Polymorphisme Humain (CEPH) and was obtained from the Coriell Institute for Medical Research. These samples also are being used by the International Haplotype Mapping (HapMap) consortium for genotyping. OAS and RNASEL gene sequencing and SNP detection. All exons of the human genes encoding the 2 -5 -OAS family (OAS1, OAS2, OAS3, and OASL) and the RNASEL gene were sequenced, to identify variants. Primer 3 software (version 1; Massachusetts Institute of Technology) was used to design primers that hybridize to flanking sequences that are at least 25 bp from each exon. A total of 46 primer pairs were designed to amplify all 5 exons and 1 splice variant of OAS1, 10 exons of OAS2, 16 exons of OAS3, 5 exons of OASL, and 5 exons of RNASEL. Genomic DNA was obtained from samples from all 33 case patients and from 16 samples from 60 control subjects, and it was amplified by polymerase chain reaction (PCR) using the exon-specific primers. All exons, as well as 25 bp contained within the 5 and 3 flanking regions of each exon, were sequenced and screened for variants. PCR was performed in 25-mL reaction volumes containing 10 ng of genomic DNA template, 5 pmol/L each of forward and reverse primer, 6.25 mL of Multiplex PCR mix (Qiagen), and 14.75 mL of high-performance liquid chromatography-grade water. PCR conditions for all amplicons were as follows: initial denaturation at 95ЊC for 15 min, followed by 40 cycles at 95ЊC for 45 s, 60ЊC for 45 s, and 72ЊC for 45 s, and a final extension at 72ЊC for 7 min. The PCR products were analyzed using 2% agarose-gel electrophoresis and were purified using 3 mL of Exo-Sap IT (USB). Sequencing of each sample was performed with ABI Big Dye Version 3.1 Terminator Cycle sequencing chemistry, and the products were analyzed on an ABI 3700 DNA sequencer (Applied Biosystems). The resulting sequences were compared with the corresponding reference sequences by use of Mutation Surveyor (version 1.0; SoftGenetics), to screen for SNPs. SNPs detected by direct DNA sequencing were confirmed within the samples that were originally tested (33 from case patients and 16 from control subjects) and were identified within the remaining 44 samples from control subjects by use of an allele-specific mutation assay called tetra primer-amplification refractory mutation system PCR (tetramer-ARMS PCR), in accordance with standard protocols [20] . The conditions for the tetramer-ARMS PCR were the same as those used for sequencing. Amplification products were resolved by agarose-gel electrophoresis, and the results were photographed.
Statistical analysis. Genotype and allele frequencies in case patients and control subjects were analyzed for associations by use of x 2 tests specific for the transmission/disequilibrium test (TDT) on 2-by-2 and 2-by-3 contingency tables. SNPassistant (version 1.0; Sunergia Medical) was used for the calculations. In this analysis, to match ethnicities, data from only white case patients were compared with data from control subjects, all of whom were white.
RESULTS
Characteristics of case patients and control subjects.
A total of 151 patients received diagnoses of WNV disease in Houston during [2002] [2003] , and 120 were contacted by an investigator. A total of 43 patients agreed to participate in the study; good-quality DNA was obtained from the blood samples from 33 of these patients. The mean age of the 33 case patients was 65 years (range, 23-77 years), 72.7% were men, 81.8% were white, 12.1% were African American, and 6.1% were Hispanic (table 1). Of the 33 case patients, 24.2% had meningitis, 60.6% had encephalitis, and 15.2% had fever. All 33 case patients were hospitalized because of their disease.
Mutational analysis of the OAS and RNASEL genes. All of the exons and their flanking sequences within each OAS and RNASEL gene were successfully sequenced in samples from all 33 case patients and in 16 samples from 60 control subjects. No deletion, insertion, or nonsense mutations were observed in any exons of any case patient or control subject. Therefore, unlike the situation in inbred mice, susceptibility to severe WNV disease in our study population did not map to a structural component of the genes within the 2-5A system of innate viral resistance.
A SNP in OASL and susceptibility to severe WNV disease. Although no mutations were detected within the exons and exon-flanking sequences of the OAS and RNASEL genes, 23 SNPs, including 8 novel ones, were identified (table 2); 16 of these SNPs were within coding regions and included 4 nonsynonymous SNPs. Six of the 8 novel SNPs were unique to the samples from case patients; all of these were within coding regions, and they included 1 SNP that caused an amino acid change from arginine to serine. To determine if any of the SNPs identified in case patients were associated with susceptibility to severe WNV disease, we performed 2-by-2 and 2-by-3 contingency table analyses on all 23 SNPs, to determine the allele and genotype frequency distributions (table 3) . Only the samples from the 27 white case patients were compared against the samples from the control subjects, all of whom were white. For the 6 known SNPs, data from publicly available HapMap genotype information were incorporated into the analysis. For the other 17 SNPs, tetramer-ARMS PCR assays were performed on the 60 samples from control subjects, to determine the genotypes of the SNPs. Contingency analysis (table 4) revealed significant P values (2-by-2, ; 2-by-3, ) for SNP rs3213545 within P p .0031 P p .000321 OASL exon 2, suggesting that this SNP is associated with increased susceptibility to severe WNV disease. SNP rs3213545 is a synonymous SNP that is located 210 bp from the 5 end of exon 2 of OASL. Eighty-four percent of the patients were homozygous for the C allele. Only 48% of control subjects were homozygous for the C allele, and 46% were C/T heterozygous.
Because rs3213545 is a synonymous SNP, we assessed whether it was acting as a marker for another functional SNP associated with susceptibility to severe WNV disease. To determine if this was the case, we used data for all SNPs within chromosome 12q24 that were genotyped by the HapMap project and determined the haplotype structure of the candidate SNP in relation to that of the neighboring SNPs. SNP rs3213545 is located within a 43-kb haplotype block that includes SNPs within the adjacent area encoding hypothetical protein FLJ12448 and TCF, a gene implicated in hepatitis virus B expression [21] and in diabetes [22] . Two SNPs within the haplotype block cause nonsynonymous changes to TCF. We genotyped 6 of the 13 known SNPs within this block in our case patients, to confirm that the haplotype structure was not altered. A haplotype analysis showed that all SNPs were within the same haplotype block (figure 2). However, a contingency table analysis of these SNPs revealed that no association between a SNP and susceptibility to severe WNV disease achieved statistical significance (table  4) . These results indicate that, of the SNPs tested within the haplotype block, rs3213545 in OASL exon 2 is the only one that is associated with susceptibility to severe WNV disease.
SNP rs3213545 in an exon splice enhancer (ESE). Although SNP rs3213545 is synonymous, recent findings suggest that a number of human diseases may be caused by codingregion nonsense, missense, and even translationally silent mutations that affect phenotypic variability by influencing splicing accuracy and efficiency [23] [24] [25] . Analysis of the surrounding sequence by use of an ESE prediction program (ESE Finder; version 2.0; Cold Spring Harbor Laboratory) showed that the reference allele C at nt 210 was part of a 7-nt (ctctCgt) ESE sequence. This sequence is predicted to be a binding site for the SF2/ASF splicing factor protein (ESE finder score, 2.663). Introduction of the variant allele T changes this ESE sequence to ctctTgt and markedly reduces the ESE finder score to 0.139, which is well below the threshold score (1.956) for an SF2/ASF protein-binding site.
DISCUSSION
To identify genetic factors involved in determining susceptibility to severe WNV disease in humans, we sequenced all exons of human genes OAS1, OAS2, OAS3, OASL, and RNASEL in 33 case patients hospitalized with WNV disease. We identified 23 SNPs, including several nonsynonymous unique ones, each of which could play a functional role in determining susceptibility to severe WNV disease. Our follow-up association study in which 60 CEPH samples were used as controls identified a mutation in OASL exon 2 (a T allele instead of C allele at nt 210 of exon 2) that abolishes a consensus ESE; this mutation was present with reduced frequency in patients with severe WNV disease. Only 16% of case patients were either homozygous or heterozygous for the T allele, whereas the percentage of control subjects with the T allele was much higher (52% were homozygous or heterozygous). Mutations within ESEs have been shown to reduce the levels of full-length transcripts and their corresponding protein [26] . These results suggest that individuals susceptible to severe WNV disease may express high- er levels of full-length OASL, which, because of its lack of OAS enzymatic activity, may serve as a dominant-negative mutant of enzymatically active OAS isozymes (OAS1, OAS2, and OAS3) and is analogous to the enzymatically inactive truncation mutant form of Oas1b in inbred mice.
In mammals, genes encoding the 2 -5 -OAS family are highly conserved and produce IFN-inducible enzymatic proteins that play an important role in the host's defense mechanisms against viral infections [27] . It has been reported that there are 12 murine OAS genes-Oas1a, Oas1b, Oas1c, Oas1d, Oas1e, Oas1f, Oas1g, Oas1h, Oas2, Oas3, OasL1, and OasL2-all localized to the 5F region; the 8 Oas1 genes, along with Oas2 and Oas3, are clustered within a 210-kb portion of the 5F region [9, 10, 28] . The 8 Oas1 genes have highly conserved exonic sequences, although each gene has a unique set of regulatory elements. Oas1c, Oas1e, Oas1g, Oas2, and Oas3 are all transcribed in the same orientation, whereas Oas1b, Oas1d, Oas1f, and Oas1h are transcribed in the opposite direction. The genes encoding the 2 OAS-like proteins (OasL1 and OasL2) are located 593 kb upstream and contain both an OAS unit and a C-terminus consisting of 2 ubiquitin-like domains. All murine Oas genes are transcribed, although they exhibit distinct and specific patterns of tissue expression [9, 18, [27] [28] [29] . Information regarding the function of each isozyme is incomplete at this time. After expression in bacteria, Oas1a, Oas1b, Oas1c, Oas1d, Oas1e, Oas1g, and Oas1h bind dsRNA, and Oas1a and Oas1g demonstrate OAS activity. Reasons for the failure of the other bacterially expressed Oas1 isozymes to demonstrate activity include (1) suboptimal assay conditions [28] ; (2) the requirement for some OAS proteins to be expressed in eukaryotic systems capable of protein glycosylation before biologically active protein can be obtained [30] ; (3) the truncation of Oas1b, which eliminated domains essential for encoding enzymatic activity in the protein; and (4) a possible lack of intrinsic OAS activity in each of the inactive isozymes.
Recent findings involving the gene encoding Oas1b have demonstrated that this isoform may be especially important for resistance to WNV disease and other flavivirus infections, at least in mice [9, 10] . Two research groups reported that a C820T nonsense mutation in exon 4 of the murine Oas1b gene was associated with susceptibility to experimental infection with WNV in inbred mouse strains. As a result of this nonsense mutation, 2 motifs that are believed to be essential for the catalytic activity of OAS are absent in the mutant copy of the Oas1b gene. The Oas1b alleles of WNV-susceptible mice encode a truncated form of the protein, whereas WNV-resistant mice have at least 1 normal copy of the gene [9, 10] . Precisely how this mutation in Oas1b results in susceptibility to WNV infection is not fully understood. In vitro studies have demonstrated that WNV replicates less efficiently in mouse neuroblastoma cells overexpressing wild-type OAS1b than in cells overexpressing the truncated form of the protein [18] , which confirmed the initial report that exogenous expression of full-length Oas1b at low levels in murine embryonic fibroblasts obtained from WNV-susceptible mice reduced viral production and cytopathic effect, compared with that in untransfected cells. However, in the initial study, although the levels of viral production and cytopathic effect were lower in inbred mice, they were not equal to the levels observed in cells from WNV-resistant mice [9] . Furthermore, higher levels of full-length Oas1b protein, paradoxically, were less effective in reducing viral production and cytopathic effect. These findings are not completely consistent with the notion that the resistance allele is dominant. Rather, these results, along with the existence of 7 other unaffected members of the Oas1 gene family in susceptible mice, leaves open the possibility that the mutant form of Oas1b can act in a dominant-negative manner.
Although our case patients did not have a nonsense mutation that was similar to the mutation associated with susceptibility to WNV infection in mice, our findings suggest the possibility that a dominant-negative mechanism involving OASL1 may be contributing to susceptibility to severe WNV disease in humans. The genes encoding the 2 -5 -OAS family in humans include 4 OAS genes (OAS1, OAS2, OAS3, and OASL1) and an OASL2 pseudogene (reviewed in [31] ). The gene order and relative distances of the human OAS genes are highly conserved between the Oas locus in mice and the orthologous region of human chromosome 12 [27, 28, 31] . OASL1 and the OASL2 pseudogene are located on chromosome 12q24.2. OASL2 contains only the first 2 OAS gene exons and is not functional [28] . OASL1 contains all 5 OAS1-like exons and an exon encoding 2 ubiquitin-like domains in the C-terminus similar to murine OasL1 and OasL2. OSL1 is transcribed and translated, but the portion encoding the OAS protein, although presum- ably able to bind to dsRNA, is enzymatically inactive, because it lacks 2 of 3 aspartate residues within b strands 2 and 5, which are important for binding catalytically active magnesium ions, and it has mutations in the P loop, which is involved in binding of the triphosphate of ATP [29, 32, 33] . Thus, full-length OASL1 in humans and truncated Oas1b in mice have the potential to serve as dominant-negative mutants of the other enzymatically active OAS isozymes within human and murine cells, respectively, perhaps by binding to dsRNA and preventing the binding and activation of enzymatically competent OAS isozymes ( figure 1 ).
Our findings demonstrate a strong association between SNP rs3213545 and susceptibility to severe WNV disease. A possible explanation for how this SNP may contribute to susceptibility to severe WNV disease is that an intact ESE within OASL1 exon 2, which was found more frequently in case patients, is likely to result in increased levels of full-length OASL1 mRNA. This prediction is based on the finding that some patients with isolated growth hormone deficiency type II have a loss-of-function mutation in an ESE within the growth hormone gene that results in decreased levels of full-length growth hormone transcripts [26] . Individuals, such as our case patients, possessing either 1 or 2 copies of the allele containing the intact ESE would be expected to have an elevated level of full-length OASL1 within their cells. This increase in the level of full-length OASL1 would enhance its dominant-negative effect, as proposed above, and lead to increased susceptibility to severe WNV disease.
On the basis of our findings and the considerations outlined above, we speculate that the mechanism for susceptibility to severe WNV disease in humans might, in fact, be similar to that proposed above at the protein level, if not at the gene level, in inbred strains of mice (figure 1). We speculate that, in humans, the enzymatically inactive full-length OASL1 protein is acting as the dominant-negative protein, whereas, in inbred mice, the truncated and enzymatically inactive Oas1b protein is the culprit. Alternatively, or in addition to SNP rs3213545, it is possible that the interaction of several SNPs identified in the present study may contribute to susceptibility to severe WNV disease.
It should be acknowledged that the size of the patient populations examined in our study was small (33 case patients and 60 control subjects). Consequently, the possibility exists that the validity of the association between SNP rs3213545 and susceptibility to severe WNV disease could have arisen by chance, because of skewing of the allele frequencies within small populations. It will be important to analyze this region in a larger group of case patients and control subjects, to confirm these findings. Of note, however, is that Haines et al. recently performed SNP analysis within chromosome 1q32 in 24 patients with severe age-related macular degeneration and 24 control subjects; SNP rs1061170 encoding variant Y402H within complement factor H was observed in 94% of case patients and 46% of control subjects [34] . These findings were confirmed by the same research group using a larger data set and by 2 other groups [35, 36] .
